Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 5/20 | 0.47 |
| ▸ | HTR2A | P28223 | 4/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | PLA2G4A | P47712 | 4/20 | 0.38 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.38 |
| ▸ | ITGAV | P06756 | 1/20 | 0.38 |
| ▸ | PRMT5 | O14744 | 5/20 | 0.37 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.36 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.36 |
| ▸ | ADA | P00813 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3360842 | 0.90 | HTR2C (0.59) | HTR2CHTR2AKDM4EMEN1MAPT | |
| SCHEMBL3360221 | 0.83 | HTR2C (0.58) | HTR2CHTR2APRMT5 | |
| SCHEMBL13282968 | 0.81 | HTR2C (0.40) | HTR2CHTR2APLA2G4A | |
| SCHEMBL4403967 | 0.79 | MTNR1A (0.46) | HTR2CHTR2AKDM4EMEN1MAPT | |
| SCHEMBL3361269 | 0.78 | NTSR1 (0.45) | HTR2CHTR2AITGB3ITGAV | |
| SCHEMBL3360887 | 0.77 | CDK4 (0.49) | HTR2CHTR2AKDM4EMEN1MAPT | |
| SCHEMBL29556369 | 0.77 | CDK4 (0.49) | HTR2CHTR2AKDM4EMEN1MAPT | |
| SCHEMBL4401260 | 0.76 | KDM4E (0.53) | HTR2CHTR2AKDM4EMEN1MAPT | |
| SCHEMBL22930091 | 0.73 | HTR2C (0.58) | HTR2CHTR2APLA2G4APRMT5 | |
| SCHEMBL4944251 | 0.71 | HTR2C (0.68) | HTR2CHTR2APRMT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7632954-B2 | Sym-N-(n-hexyl)-5-bromotriindole; Sym-N-(n-hexyl)-5-phenyltriindole; Sym-N-(n-hexyl)-[2-cyano-2-(4-pyridyl)vinyl]triindole; electrification preventions, electrification controls, capacitors, batteries, chemical sensors, displays, organic EL materials, solar cells, photodiodes, phototransistors; fibers | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 2009-12-15 | — | — | US | disclosed |
| US-20070191455-A1 | Substituted sym-triindole | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 2007-08-16 | — | — | US | disclosed |
| EP-1717239-A1 | SUBSTITUTED SYM-TRIINDOLE | Ihara Chemical Industry Co., Ltd. (JP) | 2006-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070191455-A1 | Substituted sym-triindole | RTF1, ETF1, RTF2 | HTR2C 200/4885HTR2A 74/4885KDM4E 3892/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.